Evidence map›Paper›PMID 19109909›Full record

ArticleNeuron2008

Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection.

Steven W Flavell, Tae-Kyung Kim, Jesse M Gray, David A Harmin, Martin Hemberg, Elizabeth J Hong, Eirene Markenscoff-Papadimitriou, Daniel M Bear, Michael E Greenberg

Open access · greenAbstract read
In one paragraph

Article in Neuron, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 288 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
288citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

288 citing papers in PubMed, 1 synthesis or guideline pooled it, 440 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identification of an episignature for the MEF2C-associated syndrome.European journal of human genetics : EJHG · 2026
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

228 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Steven W FlavellFM Kirby Neurobiology Center, Children's Hospital, and Department of Neurology and Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
Tae-Kyung Kim
Jesse M Gray
David A Harmin
Martin Hemberg
Elizabeth J Hong
Eirene Markenscoff-Papadimitriou
Daniel M Bear
Michael E Greenberg
Boston Children's Hospital · USHarvard University · USHarvard–MIT Division of Health Sciences and Technology · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI CHEN, CHINFEI · 1985 to 2015
$26.2M
ELECTRICAL STIMULATION OF IMMEDIATE EARLY GENESR37NS028829 · NINDS · HARVARD MEDICAL SCHOOL · PI GREENBERG, MICHAEL ELDON · 1999 to 2019
$7.4M
ELECTRICAL STIMULATION OF IMMEDIATE GENESR01NS028829 · NINDS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GREENBERG, MICHAEL ELDON · 1990 to 2024
$6.2M
NICHD NIH HHS HD18655NICHD NIH HHS P30 HD018655NINDS NIH HHS NS028829NINDS NIH HHS R01 NS028829NINDS NIH HHS R37 NS028829
6 · The paper itself

Abstract

Although many transcription factors are known to control important aspects of neural development, the genome-wide programs that are directly regulated by these factors are not known. We have characterized the genetic program that is activated by MEF2, a key regulator of activity-dependent synapse development. These MEF2 target genes have diverse functions at synapses, revealing a broad role for MEF2 in synapse development. Several of the MEF2 targets are mutated in human neurological disorders including epilepsy and autism spectrum disorders, suggesting that these disorders may be caused by disruption of an activity-dependent gene program that controls synapse development. Our analyses also reveal that neuronal activity promotes alternative polyadenylation site usage at many of the MEF2 target genes, leading to the production of truncated mRNAs that may have different functions than their full-length counterparts. Taken together, these analyses suggest that the ubiquitously expressed transcription factor MEF2 regulates an intricate transcriptional program in neurons that controls synapse development.

Indexed as

GenomicsAnalysis of VarianceAnimalsBrain MappingCell NucleusCells, CulturedChromatin ImmunoprecipitationComputational BiologyDNA-Directed RNA PolymerasesEmbryo, MammalianExploratory BehaviorHippocampusHumansMaleMEF2 Transcription FactorsMyogenic Regulatory FactorsDNA-Directed RNA PolymerasesMef2d protein, mouseMEF2 Transcription FactorsMyogenic Regulatory Factors

Identifiers

PMID19109909
PMCPMC2630178
OpenAlexW2120629185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.